RPS6KB1 and prostate cancer: To validate phospho-S6K1 (p-S6K1) inhibition by Super-EBS, we tested various lung cancer and prostate cancer cell lines treated with Super-EBS for 3 or 6 h for p-S6K1 and total protein S6K1 expression by western blot analysis.